ReadyCell is a biotechnological company focused on providing sophisticated, cell based in vitro tools and R&D services for the ADME-Tox segment. Our expertise includes the manufacturing of patented, innovative cell-based and ready-to-use plates for efficacy and safety testing of active molecules on preclinical drug discovery and development. ReadyCell developed a patented technology that allows the shipment of living plated cells at room temperature. Maintaining their full viability and cellular characteristics, and thus allowing to streamline drug discovery pipelines and reducing experimental costs. ReadyCell current Services portfolio covers a wide range of drug discovery applications for in vitro and in silico screening, including adsorption, metabolism and toxicity assays recommended by regulatory agencies.